![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:EIF5A-DNAJC24 (FusionGDB2 ID:HG1984TG120526) |
Fusion Gene Summary for EIF5A-DNAJC24 |
![]() |
Fusion gene information | Fusion gene name: EIF5A-DNAJC24 | Fusion gene ID: hg1984tg120526 | Hgene | Tgene | Gene symbol | EIF5A | DNAJC24 | Gene ID | 1984 | 120526 |
Gene name | eukaryotic translation initiation factor 5A | DnaJ heat shock protein family (Hsp40) member C24 | |
Synonyms | EIF-5A|EIF5A1|eIF-4D|eIF5AI | DPH4|JJJ3|ZCSL3 | |
Cytomap | ('EIF5A')('DNAJC24') 17p13.1 | 11p13 | |
Type of gene | protein-coding | protein-coding | |
Description | eukaryotic translation initiation factor 5A-1eukaryotic initiation factor 5Arev-binding factor | dnaJ homolog subfamily C member 241700030A21RikCSL-type zinc finger-containing protein 3DPH4 homolog (JJJ3, S. cerevisiae)DPH4, JJJ3 homologDnaJ (Hsp40) homolog, subfamily C, member 24diphthamide biosynthesis protein 4zinc finger, CSL domain contai | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P63241 | . | |
Ensembl transtripts involved in fusion gene | ENST00000336452, ENST00000336458, ENST00000416016, ENST00000419711, ENST00000571955, ENST00000572815, ENST00000573542, ENST00000576930, | ||
Fusion gene scores | * DoF score | 10 X 9 X 6=540 | 4 X 4 X 1=16 |
# samples | 10 | 4 | |
** MAII score | log2(10/540*10)=-2.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/16*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: EIF5A [Title/Abstract] AND DNAJC24 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | EIF5A(7213009)-DNAJC24(31391414), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EIF5A | GO:0006913 | nucleocytoplasmic transport | 12210765 |
Hgene | EIF5A | GO:0006915 | apoptotic process | 15371445|17187778 |
Tgene | DNAJC24 | GO:0032781 | positive regulation of ATPase activity | 22367199 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for EIF5A-DNAJC24 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for EIF5A-DNAJC24 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for EIF5A-DNAJC24 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:7213009/:31391414) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
EIF5A | . |
FUNCTION: mRNA-binding protein involved in translation elongation. Has an important function at the level of mRNA turnover, probably acting downstream of decapping. Involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. With syntenin SDCBP, functions as a regulator of p53/TP53 and p53/TP53-dependent apoptosis. Regulates also TNF-alpha-mediated apoptosis. Mediates effects of polyamines on neuronal process extension and survival. May play an important role in brain development and function, and in skeletal muscle stem cell differentiation. Also described as a cellular cofactor of human T-cell leukemia virus type I (HTLV-1) Rex protein and of human immunodeficiency virus type 1 (HIV-1) Rev protein, essential for mRNA export of retroviral transcripts. {ECO:0000269|PubMed:15371445, ECO:0000269|PubMed:15452064, ECO:0000269|PubMed:16987817, ECO:0000269|PubMed:17187778, ECO:0000269|PubMed:17360499}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for EIF5A-DNAJC24 |
![]() |
Top |
Fusion Gene PPI Analysis for EIF5A-DNAJC24 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EIF5A-DNAJC24 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EIF5A-DNAJC24 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | EIF5A | C0007097 | Carcinoma | 1 | CTD_human |
Hgene | EIF5A | C0022548 | Keloid | 1 | CTD_human |
Hgene | EIF5A | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Hgene | EIF5A | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | EIF5A | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
Hgene | EIF5A | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
Hgene | EIF5A | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
Hgene | EIF5A | C0205699 | Carcinomatosis | 1 | CTD_human |
Hgene | EIF5A | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |